Denali Therapeutics Inc (DNLI)
20.52
+0.28
(+1.38%)
USD |
NASDAQ |
May 17, 16:00
20.52
0.00 (0.00%)
Pre-Market: 20:00
Denali Therapeutics Shares Outstanding: 142.61M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| April 30, 2024 | 142.61M |
| April 05, 2024 | 142.54M |
| March 31, 2024 | 142.51M |
| February 29, 2024 | 142.40M |
| February 20, 2024 | 139.16M |
| December 31, 2023 | 138.39M |
| October 30, 2023 | 138.20M |
| September 30, 2023 | 138.05M |
| July 31, 2023 | 137.42M |
| June 30, 2023 | 137.36M |
| May 01, 2023 | 136.89M |
| April 04, 2023 | 136.74M |
| March 31, 2023 | 136.74M |
| February 21, 2023 | 136.68M |
| December 31, 2022 | 135.97M |
| October 27, 2022 | 135.81M |
| October 24, 2022 | 135.73M |
| October 03, 2022 | 123.80M |
| September 30, 2022 | 123.80M |
| August 01, 2022 | 123.35M |
| June 30, 2022 | 123.16M |
| April 28, 2022 | 122.95M |
| April 11, 2022 | 122.89M |
| March 31, 2022 | 122.86M |
| February 18, 2022 | 122.83M |
| Date | Value |
|---|---|
| December 31, 2021 | 122.28M |
| October 29, 2021 | 122.13M |
| September 30, 2021 | 122.01M |
| July 28, 2021 | 121.64M |
| June 30, 2021 | 121.53M |
| April 26, 2021 | 121.19M |
| April 12, 2021 | 121.18M |
| March 31, 2021 | 121.15M |
| February 17, 2021 | 120.98M |
| December 31, 2020 | 120.53M |
| October 28, 2020 | 119.92M |
| September 30, 2020 | 119.80M |
| September 22, 2020 | 119.29M |
| August 03, 2020 | 105.98M |
| June 30, 2020 | 105.90M |
| April 29, 2020 | 105.63M |
| April 13, 2020 | 105.61M |
| March 31, 2020 | 105.54M |
| February 19, 2020 | 105.42M |
| January 31, 2020 | 105.03M |
| December 31, 2019 | 96.19M |
| October 30, 2019 | 96.03M |
| September 30, 2019 | 95.99M |
| July 31, 2019 | 95.84M |
| June 30, 2019 | 95.66M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
95.66M
Minimum
Jun 30 2019
142.61M
Maximum
Apr 30 2024
122.63M
Average
122.56M
Median
Shares Outstanding Benchmarks
| Halozyme Therapeutics Inc | 127.27M |
| AIM ImmunoTech Inc | 49.90M |
| Perspective Therapeutics Inc | 622.63M |
| Protalix BioTherapeutics Inc | 73.32M |
| Armata Pharmaceuticals Inc | 36.15M |